The increased immunosuppressive environment of MT/Shc313F/313F tumours renders them insensitive to immune checkpoint blockade but their elevated STAT1 status may be therapeutically exploited to sensitize them to vaccination-based therapies (Fig. 6c). This evidence concerns the gene STAT1 and neoplasm.